Systematics and principles of therapy for depressive disorders in epilepsy
https://doi.org/10.17650/2222-8721-2015-5-4-32-37
Abstract
Relying on a comprehensive investigation, the author proposes the typology of depressive disorders in epilepsy by identifying ictal, preictal, interictal, and postictal conditions. Risk factors for depressive symptoms are considered. Main approaches to therapy for depressions are offered. Particular emphasis is placed on the normothymic activity of a number of anticonvulsants. Valproates, and depakine in particular, as a normothymic agent are shown to be beneficial in treating affective disorders.
About the Author
M. V. Usyukina
V.P. Serbsky Federal Medical Research Center for Psychiatry and Narcology, Ministry of Health of Russia; 23 Kropotkinsky Pereulok, Moscow, 119034, Russia
Russian Federation
Russian Federation
References
1. Dudra-Jastrzebska M., Andres-Mach M.M., Luszczki J.J., Czuczwar S.J. Mood disorders in patients with epilepsy. Pharmacol Rep 2007;59:369–78.
2. Thapar А., Kerr M., Harold G. Stress, anxiety, depression, and epilepsy: Investigating the relationship between psychological factors and seizures. Epilepsy Behav 2009;14: 134–40.
3. Kanner A.M. The treatment of depressive disorders in epilepsy: what all neurologists should know. Epilepsia 2013;54(Suppl):3–12. doi: 10.1111/epi.12100.
4. Gandey A. Patients with epilepsy have high comorbidity rates. AES 2008: American Epilepsy Society and Annual Meeting, 2008. Р. 28.
5. Reynolds E.H. Folic acid, ageing, depression, and dementia. BMJ 2002;324:1512–5.
6. La France W.C. Jr, Kanner A.M., Hermann B. Psychiatric comorbidities in epilepsy. Neurobiology 2008;83:347–83.
7. Mehmedika-Suljić E. Presence of depressive disorder among patients with epilepsy in relation to the duration of illness and type of antiepileptic therapy. Epilepsia 2008;62(3):56–8.
8. Akanuma N., Hara E., Adachi N. et al. Psychiatric comorbidity in adult patients with idiopathic generalized epilepsy. Epilepsy Behav 2008;13(1):248–51.
9. Kimiskidis V.K., Triantafyllou N.I., Kararizou E. Depression and enxiety in epilepsy: the association with demografic and seizure-related variabeles. Ann Gen Psych 2007;6:28.
10. Kanner A. Depression and epilepsy. A new perspective on two closely related disorders. Epilepsy currents 2006;6(5):141–6.
11. Koh S., Magid R., Chung H. et al. Depressive behavior and selective down– regulation of serotonin receptor expression after early–life seizures: reversal by environmental enrichment. Epilepsy Behav 2007;10(1):26–31.
12. Cramer J. Stress, genes, and neuroanatomy contribute to depression in epilepsy. 27th International Epilepsy Congress Proceedings Singapore. 2007. Pp. 65–87.
13. Elger C.E., Schmidt D. Modern management of epilepsy: a practical approach. Epilepsy Behav 2008;12:501–39.
14. Рогачева Т. А., Мельникова Т. С. Депрессивные расстройства у больных эпилепсией в период ремиссии. Журнал неврологии и психиатрии им. С.С. Корсакова 2012;(11):86–90. [Rogacheva T.A., Melnikova T.S. Depressive disorders in epileptic patients in remission. Zhurnal nevrologii i psikhiatrii im. S.S. Korsakova = S.S. Korsakov Journal of Neurology And Psychiatry 2012;(11):86–90. (In Russ.)].
15. Полянский Д.А. Клинико-терапевтические факторы риска суицидального поведения у больных эпилепсией. Автореф. дис. … канд. мед. наук. М., 2003. 30 с. [Polyansky D.A. Clinical and therapeutic risk factors for suicidal behavior in patients with epilepsy. Аuthor’s abstract of thesis … of candidate medical sciences. Moscow, 2003. 30 p. (In Russ.)].
16. Зенков Л.Р., Яхно Н.Н., Усачева Е.Л. Депакин хроно в лечении эпилепсии, резистентной к другим препаратамю. Неврологический журнал 2000;5(4):39–42. [Zenkov L.R., Yakhno N.N., Usacheva E.L. Depakine chrono in the treatment of epilepsy resistant to other drugs. Nevrologicheskiy zhurnal = of Neurological Journal 2000;5(4):39–42. (In Russ.)].
17. Зенков Л.Р. Фармакологическое лечение эпилепсии. Русский медицинский журнал 2000;(10):411–7. 17. [Zenkov L.R. Pharmacological treatment of epilepsy. Russkiy meditsinskiy zhurnal = Russian Journal of Medicine 2000;(10):411–7. (In Russ.)].
18. Мосолов С.Н., Костюкова Е.Г, Федотов Д.Д. Дифференцированный прогноз эффективности профилактической терапии ламотрижином, вальпроатом и топираматом у больных с частыми рецидивами БАР первого и второго типа. Социальная и клиническая психиатрия 2014;24(3):77–83. [Mosolov S.N., Kostyukova E.G., Fedotov D.D. Differential prediction of the efficiency of preventive therapy with lamotrigine, valproate, and topiramate in patients with frequent recurrences of bipolar affective disorders I and II. Sotsialnaya i klinicheskaya psikhiatriya = Social and Clinical Psychiatry 2014;24(3):77–83. (In Russ.)].
19. Loring D.W., Meador K.J. Cognitive and behavioral effects of epilepsy treatment. Epilepsia 2001;42(Suppl. 8):24–32.
Review
For citations:
Usyukina M.V. Systematics and principles of therapy for depressive disorders in epilepsy. Neuromuscular Diseases. 2015;5(4):32-37. (In Russ.) https://doi.org/10.17650/2222-8721-2015-5-4-32-37
Views:
840
Email this article 